|
시장보고서
상품코드
2087819
기존 창상관리 용품 시장 : 제품 유형, 창상 유형, 소재 유형, 멸균 상태, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)Traditional Wound Care Supplies Market by Product Type, Wound Type, Material Type, Sterility, End User, Distribution Channel - Global Forecast 2026-2032 |
||||||
360iResearch
기존 창상관리 용품 시장은 2032년까지 연평균 복합 성장률(CAGR) 6.73%로 성장해 129억 3,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 81억 9,000만 달러 |
| 추정 연도(2026년) | 87억 3,000만 달러 |
| 예측 연도(2032년) | 129억 3,000만 달러 |
| CAGR(%) | 6.73% |
기존 창상관리 용품은 병원, 당일 수술센터, 진료소, 장기 요양 시설, 재택치료 및 응급 처치 현장에서 창상관리 운영의 기반이 되어 왔습니다. 거즈 드레싱, 면 롤, 반창고, 의료용 테이프, 복부용 패드, 스펀지, 상처 세정제, 비접착성 드레싱 등의 주요 제품은 세정, 보호, 삼출액 흡수, 압박 지지 및 2차 드레싱 용도로 널리 사용되고 있습니다.
이러한 수요는 뿌리 깊은 임상적 필요성에 의해 뒷받침되고 있습니다. 급성 외상, 수술 상처, 화상, 욕창, 하지 정맥성 궤양, 당뇨병성 족부 궤양 등에 대해서는 신뢰성이 높고, 구하기 쉬우며, 비용 대비 효과가 뛰어난 창상관리 용품에 대한 수요가 계속해서 이어지고 있습니다. 이 과제는 검증된 공중보건 지표를 통해 더욱 뒷받침되고 있습니다. 예를 들어, 국제당뇨병연맹(IDF)의 추산에 따르면 2021년에는 5억 3,700만 명의 성인이 당뇨병을 앓고 있었으며, 세계보건기구(WHO)의 예측에 따르면 2030년까지 전 세계 인구의 6명 중 1명이 60세 이상이 될 것으로 전망됩니다. 이러한 추세로 인해, 첨단 창상관리 기술이 확대되고 있는 상황에서도 기존 창상관리 용품은 여전히 필수적인 역할을 하고 있습니다.
창상관리 분야의 혁신적인 변화
기존 창상관리 용품 분야는 수량 위주의 조달에서 근거에 기반한 제품 선정, 표준화된 창상관리 프로토콜, 그리고 회복탄력성을 중시하는 조달 방식으로 점차 전환되고 있습니다. 특히 수술 건수가 회복되고 만성 상처 사례가 증가하는 가운데, 의료 시스템에서는 제품의 합리적인 가격과 감염 예방, 공급의 지속성, 임상 업무 흐름의 효율성 간의 균형을 점점 더 중요시하고 있습니다.
인공지능(AI)의 누적 영향
인공지능(AI)은 기존 창상관리 용품을 대체하는 것이 아닙니다. 오히려, 이러한 수요 예측, 선정, 유통 및 모니터링 방식을 재구축하고 있습니다. AI를 활용한 수요 계획을 통해 제조업체와 유통업체는 병원, 소매 약국, 재택치료 채널에서의 거즈, 드레싱, 테이프, 세정 제품의 소비 패턴을 예측하여 재고 부족이나 과잉 재고를 줄일 수 있습니다.
주요 지역에 대한 인사이트
아시아태평양은 중국, 인도, 일본, 한국, 호주 등 여러 국가에서 환자 수 증가, 병원 네트워크의 확대, 수술 건수 증가, 당뇨병 유병률의 상승으로 인해 기존 창상관리 용품 시장에 있어 고성장 지역으로 부상하고 있습니다. 또한, 의료 접근성 개선, 현지 생산 능력 향상, 그리고 1차 의료, 지역 의료, 노인 돌봄 서비스에 대한 정부 투자가 이러한 성장을 뒷받침하고 있습니다. 이 지역 수요 동향은 병원의 창상관리와 소매점 및 전자상거래 채널을 통한 일반 소비자의 구급용품 사용 증가, 이 두 가지 요인에 의해 형성되고 있습니다.
주요 그룹 분석
아세안 시장에서는 의료 제도상 1차 의료, 외과 수술 역량, 소매 약국 이용 편의성, 지역 밀착형 치료가 확대됨에 따라 기존 창상관리 용품의 중요성이 점점 더 커지고 있습니다. 현지 수요는 공공 조달, 민간 병원, 의료 관광, 그리고 소비자들의 응급용품 사용 증가가 복합적으로 작용하여 형성되고 있습니다. GCC 국가들은 1인당 의료비 지출이 높고, 조달이 일원화되어 있으며, 병원 현대화 프로그램이 추진되고 있을 뿐만 아니라, 병원, 전문 클리닉, 응급의료 네트워크를 위한 신뢰성 높은 의료 소모품에 대한 관심이 높아지고 있는 등 각기 다른 특징을 보이고 있습니다.
주요 국가에 대한 인사이트
미국은 수술 건수가 많고, 대규모 재택의료 부문이 발달해 있으며, 당뇨병 및 만성 상처로 인한 부담이 크기 때문에 기존 창상관리 용품의 주요 수요 시장으로 자리 잡고 있습니다. CDC 자료에 따르면, 2021년 기준 미국에서는 3,840만 명이 당뇨병을 앓고 있었습니다. 캐나다에서는 표준화된 조달, 감염 예방, 그리고 각 주의 의료 시스템 전반에 걸친 폭넓은 접근성이 중시되고 있습니다. 한편, 멕시코에서는 민간 의료의 확대, 의료 관광, 그리고 응급처치 용품에 대한 소매 접근성 확대가 호재로 작용하고 있습니다. 브라질은 병원 확충, 공적 의료보험 적용 범위 확대, 그리고 상처 드레싱, 거즈, 테이프, 세척 용품이 필요한 대규모 환자층을 통해 라틴아메리카 수요를 뒷받침하고 있습니다.
업계 리더를 위한 실천적인 제안
업계 리더는 거즈, 테이프, 드레싱, 면 제품, 상처 세척 용품에 대해 탄탄하고 광범위한 조달 전략을 우선시해야 합니다. 공급업체 적격성 평가, 원자재 가시화, 멸균 타당성 확인, 물류 모니터링 및 비상 시 재고 계획은 의료 서비스 제공업체를 재고 부족, 품질 문제, 가격 변동으로부터 보호하기 위해 필수적입니다.
조사 방법
본 요약 보고서는 기존 창상관리 용품과 관련된 공중보건 데이터, 규제 정보, 의료 이용 동향, 조달 동향 및 업계 모범 사례를 통합한 체계적인 2차 조사 방식을 통해 작성되었습니다. 검증된 정보 출처로는 세계 보건 기구, 각국의 보건 통계, 임상 지침, 보험 급여 체계, 의료기기 규제 관련 자료, 그리고 공개된 공급망 정보 등이 포함됩니다.
결론
기존 창상관리 용품은 가격이 저렴하고 구하기 쉬우며, 임상 현장에서 친숙하고, 거의 모든 의료 현장에서 필요로 하고 있기 때문에 전 세계 의료 분야에서 계속해서 중요한 역할을 수행하고 있습니다. 첨단 치료법이 주목을 받는 한편, 거즈, 붕대, 테이프, 패드, 상처 세척제 등의 기초적인 제품은 급성기 치료, 만성 창상관리, 수술 후 회복, 외상 대응, 재택 치료에 있어 여전히 필수적입니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향(2026년)
제7장 기존 창상관리 용품 시장 : 제품 유형별
제8장 기존 창상관리 용품 시장 : 창상 유형별
제9장 기존 창상관리 용품 시장 : 소재 유형별
제10장 기존 창상관리 용품 시장 : 멸균 상태별
제11장 기존 창상관리 용품 시장 : 최종 사용자별
제12장 기존 창상관리 용품 시장 : 유통 채널별
제13장 기존 창상관리 용품 시장 : 지역별
제14장 기존 창상관리 용품 시장 : 그룹별
제15장 기존 창상관리 용품 시장 : 국가별
제16장 경쟁 구도
제17장 기업 개요
KTH 26.07.21The Traditional Wound Care Supplies Market is projected to grow by USD 12.93 billion at a CAGR of 6.73% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 8.19 billion |
| Estimated Year [2026] | USD 8.73 billion |
| Forecast Year [2032] | USD 12.93 billion |
| CAGR (%) | 6.73% |
Traditional wound care supplies remain the operational backbone of wound management across hospitals, ambulatory surgery centers, clinics, long-term care facilities, home healthcare, and emergency response settings. Core products such as gauze dressings, cotton rolls, adhesive bandages, medical tapes, abdominal pads, sponges, wound cleansers, and non-adherent dressings are widely used for cleansing, protection, exudate absorption, compression support, and secondary dressing applications.
Demand is supported by a durable clinical need: acute injuries, surgical wounds, burns, pressure injuries, venous leg ulcers, and diabetic foot ulcers continue to require reliable, accessible, and cost-effective wound care supplies. The burden is reinforced by verified public health indicators, including the International Diabetes Federation's estimate of 537 million adults living with diabetes in 2021 and the World Health Organization's projection that one in six people globally will be aged 60 years or older by 2030. These trends make traditional wound care supplies essential even as advanced wound care technologies expand.
Transformative Shifts in the Wound Care Landscape
The traditional wound care supplies landscape is shifting from volume-driven procurement toward evidence-based product selection, standardized wound protocols, and resilience-focused sourcing. Healthcare systems are increasingly balancing product affordability with infection prevention, supply continuity, and clinical workflow efficiency, particularly as surgical volumes recover and chronic wound cases rise.
A major transformation is the movement of wound care into lower-cost sites, including outpatient clinics and home healthcare. This trend increases demand for easy-to-use adhesive bandages, gauze pads, cohesive wraps, tapes, and pre-packed wound care kits. At the same time, hospitals and distributors are reassessing supplier diversification, inventory visibility, and packaging efficiency following pandemic-era disruptions that exposed vulnerabilities in medical supply chains.
Cumulative Impact of Artificial Intelligence
Artificial intelligence is not replacing traditional wound care supplies; it is reshaping how they are forecast, selected, distributed, and monitored. AI-enabled demand planning can help manufacturers and distributors anticipate consumption patterns for gauze, dressings, tapes, and cleansing products across hospitals, retail pharmacies, and home healthcare channels, reducing stockouts and excess inventory.
Clinically, AI-assisted wound imaging and documentation tools are improving wound measurement, risk stratification, and treatment adherence. These tools can support more consistent decisions about dressing change frequency, exudate management, and escalation to advanced therapies. The cumulative impact is a more data-driven supply ecosystem in which traditional products remain indispensable but are increasingly integrated into digital care pathways, claims analytics, and value-based purchasing programs.
Key Regional Insights
Asia-Pacific is a high-growth region for traditional wound care supplies due to large patient populations, expanding hospital networks, rising surgical procedures, and increasing diabetes prevalence in countries such as China, India, Japan, South Korea, and Australia. Growth is further supported by improving healthcare access, local manufacturing capacity, and government investment in primary, community, and elderly care services. The region's demand profile is shaped by both hospital-based wound management and rising consumer use of first-aid supplies through retail and e-commerce channels.
North America remains a mature, high-utilization region supported by advanced hospital infrastructure, strong home healthcare penetration, and a significant chronic wound burden linked to aging, obesity, diabetes, and vascular disease. Europe demonstrates steady demand through universal and publicly funded healthcare systems, while reimbursement discipline encourages cost-effective wound care protocols, standardized purchasing, and compliance with medical device regulations. Latin America is expanding through private healthcare investment and improving distribution networks, with Brazil and Mexico serving as key demand centers for gauze, adhesive bandages, medical tapes, and wound cleansing products.
The Middle East is seeing increased procurement of hospital consumables as GCC countries invest in healthcare modernization, medical tourism, and emergency preparedness. Africa shows long-term opportunity driven by population growth, trauma care needs, maternal health services, surgical access programs, and infectious disease management, although market development depends on affordability, procurement transparency, local availability, and last-mile distribution capacity.
Key Group Insights
ASEAN markets are increasingly important for traditional wound care supplies as healthcare systems expand primary care, surgical capacity, retail pharmacy access, and community-based treatment. Local demand is shaped by a mix of public procurement, private hospitals, medical tourism, and rising consumer use of first-aid products. The GCC presents a different profile, with high per-capita healthcare spending, centralized procurement, hospital modernization programs, and strong interest in reliable medical consumables for hospitals, specialty clinics, and emergency care networks.
The European Union remains a major standards-driven market where regulatory compliance, product traceability, quality documentation, and sustainability expectations influence supplier selection for gauze dressings, tapes, cotton products, and wound cleansers. BRICS countries offer scale, manufacturing potential, and rising procedure volumes, but pricing pressure, tender complexity, and regional distribution gaps require localized strategies. G7 markets continue to prioritize quality, supply assurance, clinical evidence, and home healthcare compatibility, while NATO-aligned healthcare systems place additional emphasis on emergency readiness, trauma care supplies, disaster response inventories, and strategic stockpiles for civil and defense health infrastructure.
Key Country Insights
The United States is the leading demand center for traditional wound care supplies due to high surgical volumes, a large home healthcare sector, and a substantial burden of diabetes and chronic wounds; CDC data show that 38.4 million people in the U.S. had diabetes in 2021. Canada emphasizes standardized procurement, infection prevention, and broad access across provincial health systems, while Mexico benefits from expanding private healthcare, medical tourism, and growing retail access to first-aid products. Brazil anchors Latin American demand through hospital expansion, public health coverage, and a large patient base requiring wound dressings, gauze, tapes, and cleansing supplies.
In Europe, the United Kingdom, Germany, France, Italy, and Spain represent established markets supported by aging populations, public reimbursement structures, wound management guidelines, and widespread use of outpatient and community care pathways. Russia maintains demand through hospital-based care, domestic supply priorities, and public procurement needs. China and India are scale-driven markets where diabetes prevalence, surgical growth, trauma care, and healthcare infrastructure expansion support rising consumption of traditional wound care supplies. Japan and South Korea emphasize quality, infection prevention, elderly care, and clinical standardization, while Australia combines advanced clinical standards with strong community care, aged-care, and remote healthcare demand.
Actionable Recommendations for Industry Leaders
Industry leaders should prioritize resilient, multi-region sourcing strategies for gauze, tapes, dressings, cotton-based products, and wound cleansing supplies. Supplier qualification, raw material visibility, sterilization validation, logistics monitoring, and contingency inventory planning are essential to protect healthcare providers from stockouts, quality issues, and price volatility.
Manufacturers should also invest in differentiated packaging, sterilization assurance, skin-friendly adhesives, sustainable materials, and procedure-specific wound care kits. Commercial teams can strengthen competitive positioning by aligning products with home healthcare workflows, value-based procurement requirements, clinical standardization, and distributor digital platforms. Partnerships with AI-enabled inventory, wound documentation, and demand planning providers can also improve supply visibility, purchasing efficiency, and clinical relevance.
Research Methodology
This executive summary is developed using a structured secondary research approach that synthesizes public health data, regulatory information, healthcare utilization trends, procurement signals, and industry best practices relevant to traditional wound care supplies. Verified sources considered include global health agencies, national health statistics, clinical guidelines, reimbursement frameworks, medical device regulatory resources, and publicly available supply chain information.
The analysis applies market segmentation by product type, end-use setting, distribution channel, region, economic group, and country. Findings are validated through cross-comparison of demographic trends, chronic disease indicators, surgical care demand, healthcare infrastructure expansion, wound management practices, and purchasing behavior to ensure that conclusions are evidence-based, commercially relevant, and suitable for executive decision-making.
Conclusion
Traditional wound care supplies continue to play a critical role in global healthcare because they are affordable, accessible, clinically familiar, and necessary across nearly every care setting. While advanced therapies gain attention, foundational products such as gauze, bandages, tapes, pads, and wound cleansers remain essential for acute care, chronic wound management, post-surgical recovery, trauma response, and home-based treatment.
The market's future will be shaped by aging populations, diabetes prevalence, outpatient care growth, supply chain resilience, infection prevention requirements, and AI-enabled operational intelligence. Organizations that combine product reliability with digital visibility, regulatory compliance, sustainable sourcing, and localized distribution will be best positioned to meet sustained demand in both mature and emerging healthcare systems.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Traditional Wound Care Supplies Market, by Product Type
- 7.1. Bandages
- 7.1.1. Adhesive Bandages
- 7.1.2. Elastic Bandages
- 7.1.3. Cohesive bandages
- 7.1.4. Crepe bandages
- 7.2. Dressings
- 7.2.1. Alginate Dressings
- 7.2.2. Collagen Dressings
- 7.2.3. Film Dressings
- 7.2.4. Foam Dressings
- 7.2.5. Hydrocolloid Dressings
- 7.2.6. Hydrogel Dressings
- 7.3. Medical Tapes
8. Traditional Wound Care Supplies Market, by Wound Type
- 8.1. Acute Wounds
- 8.1.1. Abrasions
- 8.1.2. Lacerations
- 8.1.3. Punctures
- 8.2. Burn Wounds
- 8.2.1. First Degree Burns
- 8.2.2. Second Degree Burns
- 8.2.3. Third Degree Burns
- 8.3. Chronic Wounds
- 8.3.1. Diabetic Foot Ulcers
- 8.3.2. Pressure Ulcers
- 8.3.3. Venous Leg Ulcers
- 8.4. Surgical Wounds
9. Traditional Wound Care Supplies Market, by Material Type
- 9.1. Natural Materials
- 9.1.1. Cotton
- 9.1.2. Wool
- 9.1.3. Silk
- 9.2. Synthetic Materials
- 9.2.1. Polyester
- 9.2.2. Polyurethane
- 9.2.3. Polyethylene
- 9.2.4. Rayon
10. Traditional Wound Care Supplies Market, by Sterility
- 10.1. Sterile
- 10.2. Non-sterile
11. Traditional Wound Care Supplies Market, by End User
- 11.1. Ambulatory Care Centers
- 11.2. Clinics
- 11.3. Home Healthcare
- 11.4. Hospitals
12. Traditional Wound Care Supplies Market, by Distribution Channel
- 12.1. Online
- 12.2. Offline
13. Traditional Wound Care Supplies Market, by Region
- 13.1. Asia-Pacific
- 13.2. North America
- 13.3. Latin America
- 13.4. Europe
- 13.5. Middle East
- 13.6. Africa
14. Traditional Wound Care Supplies Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
15. Traditional Wound Care Supplies Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
16. Competitive Landscape
- 16.1. Market Concentration Analysis, 2025
- 16.1.1. Concentration Ratio (CR)
- 16.1.2. Herfindahl Hirschman Index (HHI)
- 16.2. Recent Developments & Impact Analysis, 2025
- 16.3. Product Portfolio Analysis, 2025
- 16.4. Benchmarking Analysis, 2025
17. Company Profiles
- 17.1. 3M Company
- 17.2. AdvaCare Pharma
- 17.3. Andover Healthcare, Inc.
- 17.4. B. Braun SE
- 17.5. Baxter International Inc.
- 17.6. Becton, Dickinson and Company
- 17.7. Beiersdorf AG
- 17.8. Cardinal Health, Inc.
- 17.9. Coloplast A/S
- 17.10. ConvaTec Group plc
- 17.11. DermaRite Industries, LLC
- 17.12. DeRoyal Industries, Inc.
- 17.13. Dukal Corporation
- 17.14. Dynarex Corporation
- 17.15. Essity Aktiebolag
- 17.16. Hollister Incorporated
- 17.17. Integra LifeSciences Holdings Corporation
- 17.18. Johnson & Johnson Services, Inc.
- 17.19. Kenvue Inc.
- 17.20. Lohmann & Rauscher GmbH & Co. KG
- 17.21. McKesson Corporation
- 17.22. Medicom Group
- 17.23. Medline Industries, LP
- 17.24. Molnlycke Health Care AB
- 17.25. Nitto Denko Corporation
- 17.26. Owens & Minor, Inc.
- 17.27. Paul Hartmann AG
- 17.28. Smith & Nephew plc
- 17.29. Solventum Corporation
- 17.30. Winner Medical Co., Ltd.
